tobessebot
Joined 11 years ago
Joined 11 years ago
Interesting podcasts for more background:
https://www.bloomberg.com/news/articles/2021-11-25/the-white...
https://podcasts.apple.com/us/podcast/gene-seroka-on-the-log...
https://en.wikipedia.org/wiki/EPR_(nuclear_reactor)#Flamanvi...
"Would you say that you are free to express your opinion in public or do you have to be careful with certain or many topics?" („Würden Sie sagen, man kann seine Meinung in der Öffentlichkeit frei äußern oder muss man bei einigen oder vielen Themen vorsichtig sein?“)
As a German, I believe that I am free to express my opinion, nevertheless I would say that there are obviously many topics of discussion where one has to be careful just because there is lots of potential to be misunderstood.
How am I supposed to answer this poll?
This is about mRNA vaccines, but similar things exist for viral vector vaccines as well. Technology transfer, bioreactor bags, fill-finish capacity, all of these things are bottlenecked till next year basically.
This isn't going to help India or anyone in the short term and there'll be more than enough doses for every person on Earth by next year. Why should they not retain the IP rights to make a profit on new generations that need to be vaccinated or potential booster shots? The manufacturing capacity will have been built up so scarcity won't be a problem at that point.